

The primary outcome measures used in this study was the Bergen Insomnia, as well as the Functional Outcomes of Sleep Questionnaire, Pittsburgh Sleep Diary, Short Form-36 Health Survey, and the Depression, Anxiety, and Stress Scale. In this 28-day, randomized, double-blind, placebo-controlled trial, 100 adults with self-reported poor sleep received either a placebo or a standardized Bacopa monnieri extract (150 mg twice daily).
SMARTSLEEP RESEARCH ARTICLES TRIAL
The aim of this human trial was to examine the effects of a Bacopa monnieri extract (Bacognize ®) on sleep, quality of life, and fatigue in adults with self-reported poor sleep.Ĭhanges in several salivary hormones associated with stress, sleep, fatigue, and inflammation were also evaluated to help elucidate the potential mechanisms of action associated with Bacopa monnieri supplementation.

Additional research has shown Bacopa monnieri to influence the HP-axis, which impacts sleep, as well as concentrations of the “feel-good” neurotransmitters dopamine and serotonin. monnieri functions as a nootropic, improving memory and mental acuity. More recent research has demonstrated that B. Several previous studies have demonstrated that Bacopa monnieri has adaptogenic, anti-inflammatory and neuroprotective effects. “Smart sleep” is slumber followed by waking up alert, energized and with a strong sense of well-being, even if the night’s sleep was a bit choppy.īacognize ® is a proprietary, clean-label extract standardized to bacopa glycosides for adaptogenic support targeting cognitive wellness, memory, learning, focus, attention, mood, stress management, emotional balance, and now for circadian rhythm balance for improved quality of life and quality of sleep. Cognitive function and mental energy are directly impacted by sleep quality more than hours slept.Ī new study shows that supplementing with Bacopa monnieri (as Bacognize ®) helps create the ultimate night’s smart sleep. Sleeping eight hours a night may be considered good, but perhaps it isn’t great.

